Semax vs NA Semax Amidate: What’s the Difference?

Research Disclaimer: This article is for educational and informational purposes only. All peptides discussed are for laboratory and research use only. Not for human consumption. Always consult a qualified healthcare professional.

By the NorthPeptide Research Team

Origins: Both Derived from ACTH(4-10)

Semax is a synthetic heptapeptide — Met-Glu-His-Phe-Pro-Gly-Pro — originally developed by the Institute of Molecular Genetics of the Russian Academy of Sciences in the 1980s. It is a modified fragment of adrenocorticotropic hormone (ACTH), specifically the 4-10 sequence, with a proline-glycine-proline (PGP) extension added to improve stability.

NA Semax Amidate is a further modification of Semax. “NA” refers to N-acetylation at the amino terminus, and “Amidate” refers to C-terminal amidation. These two chemical modifications have meaningful effects on how the peptide behaves in the body.

What N-Acetylation Does

N-acetylation — the addition of an acetyl group to the peptide’s N-terminus — protects the compound from degradation by aminopeptidases, enzymes that cleave peptides from their N-terminal end. This modification extends the peptide’s half-life in biological fluids compared to the unmodified version.

Research suggests N-acetylated peptides also tend to have enhanced lipophilicity (fat solubility), which can improve their ability to cross the blood-brain barrier. For a nootropic/neuroprotective peptide like Semax — whose target is the central nervous system — this matters.

What C-Terminal Amidation Does

Amidation replaces the free carboxyl group at the C-terminus with an amide group. This mirrors how many naturally occurring neuropeptides are structured — a large proportion of bioactive peptides in the brain are C-terminally amidated. The modification provides resistance to carboxypeptidases (enzymes that degrade from the C-terminal end) and is associated with enhanced receptor binding affinity for many neuropeptides.

Potency and Duration

The combined effect of N-acetylation and C-terminal amidation is that NA Semax Amidate is generally considered more potent than standard Semax on a per-milligram basis, with a longer duration of action. Researchers working with NA Semax Amidate typically use lower doses than would be used with standard Semax to achieve comparable neurological activity.

This is not a strict equivalence ratio — individual responses vary, and the research base for direct dose-to-dose comparisons in humans is limited. But the general principle is well-established in peptide pharmacology: structural modifications that increase metabolic stability tend to reduce the dose required for equivalent effect.

Mechanism of Action: What’s Shared

Both compounds share Semax’s core mechanisms:

• Upregulation of brain-derived neurotrophic factor (BDNF) — supporting neuronal growth and plasticity
• Modulation of dopaminergic and serotonergic systems
• Influence on the melanocortin receptor system
• Neuroprotective effects in models of ischemia and cognitive impairment

The NA Amidate form accesses these same targets but with greater efficiency due to improved CNS penetration and metabolic stability.

View Semax →
View NA Semax Amidate →

Administration Routes

Both Semax and NA Semax Amidate have historically been administered intranasally in Russian clinical contexts — intranasal delivery bypasses first-pass metabolism and provides a relatively direct route to the central nervous system. Subcutaneous injection is also used in research settings. Oral administration is not considered effective due to rapid proteolytic degradation in the GI tract.

Which Version for Which Research Context?

Standard Semax has a longer documented research history and a larger body of published data, primarily from Russian neurological research. It is well-characterized in models of stroke, ADHD-like conditions, and cognitive impairment. If replication of existing published research protocols is the goal, standard Semax is the more straightforward choice.

NA Semax Amidate is preferred by researchers looking for greater potency per dose and potentially longer-lasting CNS activity. Its modified structure is better suited for studies examining dose-efficiency relationships or for models where reduced dosing frequency is desirable.

Summary Comparison

References

Disclaimer: This content is for research and educational purposes only. Not medical advice. All peptides are for laboratory use only and not intended for human consumption.